Ipsen (IPSEF) Inventories, Raw Materials & Components : $68 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Ipsen Inventories, Raw Materials & Components?

Ipsen's inventories, raw materials & components for the quarter that ended in Dec. 2023 was $68 Mil.

Ipsen's quarterly raw materials increased from Dec. 2022 ($49 Mil) to Jun. 2023 ($61 Mil) and increased from Jun. 2023 ($61 Mil) to Dec. 2023 ($68 Mil).

Ipsen's annual raw materials declined from Dec. 2021 ($67 Mil) to Dec. 2022 ($49 Mil) but then increased from Dec. 2022 ($49 Mil) to Dec. 2023 ($68 Mil).

Ipsen Inventories, Raw Materials & Components Historical Data

The historical data trend for Ipsen's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen Inventories, Raw Materials & Components Chart

Ipsen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Raw Materials & Components

Get a 7-Day Free Trial

61.89

66.18

66.67

49.15

67.50

Ipsen Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Inventories, Raw Materials & Components	Get a 7-Day Free Trial															45.24	49.15	60.89	67.50	-

Ipsen Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Ipsen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (OTCPK:IPSEF) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

Traded in Other Exchanges

IPSEY:USA IPNp:UK 0MH6:UK IPN:France I7G:Germany

Address

65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100

Website

https://www.ipsen.com

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.